1. Home
  2. WVE vs HE Comparison

WVE vs HE Comparison

Compare WVE & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • HE
  • Stock Information
  • Founded
  • WVE 2012
  • HE 1891
  • Country
  • WVE Singapore
  • HE United States
  • Employees
  • WVE N/A
  • HE N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • HE Electric Utilities: Central
  • Sector
  • WVE Health Care
  • HE Utilities
  • Exchange
  • WVE Nasdaq
  • HE Nasdaq
  • Market Cap
  • WVE 2.1B
  • HE 1.8B
  • IPO Year
  • WVE 2015
  • HE N/A
  • Fundamental
  • Price
  • WVE $10.99
  • HE $9.17
  • Analyst Decision
  • WVE Strong Buy
  • HE Hold
  • Analyst Count
  • WVE 10
  • HE 3
  • Target Price
  • WVE $21.60
  • HE $10.67
  • AVG Volume (30 Days)
  • WVE 1.0M
  • HE 3.5M
  • Earning Date
  • WVE 03-05-2025
  • HE 02-11-2025
  • Dividend Yield
  • WVE N/A
  • HE N/A
  • EPS Growth
  • WVE N/A
  • HE N/A
  • EPS
  • WVE N/A
  • HE N/A
  • Revenue
  • WVE $53,610,000.00
  • HE $3,689,272,000.00
  • Revenue This Year
  • WVE N/A
  • HE $3.17
  • Revenue Next Year
  • WVE $48.58
  • HE N/A
  • P/E Ratio
  • WVE N/A
  • HE N/A
  • Revenue Growth
  • WVE N/A
  • HE N/A
  • 52 Week Low
  • WVE $3.50
  • HE $7.61
  • 52 Week High
  • WVE $16.74
  • HE $18.19
  • Technical
  • Relative Strength Index (RSI)
  • WVE 34.06
  • HE 44.97
  • Support Level
  • WVE $10.57
  • HE $9.69
  • Resistance Level
  • WVE $12.03
  • HE $10.01
  • Average True Range (ATR)
  • WVE 0.69
  • HE 0.37
  • MACD
  • WVE -0.17
  • HE -0.00
  • Stochastic Oscillator
  • WVE 12.54
  • HE 54.23

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HE Hawaiian Electric Industries Inc.

Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.

Share on Social Networks: